Our Healthcare Financial Due Diligence team delivered a detailed quality-of-earnings analysis focused on key financial considerations, such as revenue recognition timing differences related to telehealth billing cycles, accrued compensation for clinical staff, normalization of pharmaceutical and supplement inventory levels, and other adjustments to operating expenses, to a leading telehealth practice.

We worked closely with the client from kickoff through closing, providing strategic counsel on purchase agreement provisions, transaction rollforward procedures, and working capital mechanics. This proactive partnership ensured the buyer had complete visibility into transaction risks and opportunities associated with the virtual care delivery model and proprietary clinical programs.